Erlotinib and bevacizumab combination therapy for afatinib-refractory leptomeningeal carcinomatosis from EGFR-mutated lung cancer
Abe, Miyuki, Osoegawa, Atsushi, Karashima, Takashi, Takumi, Yohei, Kobayashi, Ryoji, Hashimoto, Takafumi, Miyawaki, Michiyo, Takeuchi, Hideya, Okamoto, Tatsuro, Sugio, KenjiVolume:
8
Language:
english
Journal:
International Cancer Conference Journal
DOI:
10.1007/s13691-019-00358-6
Date:
April, 2019
File:
PDF, 941 KB
english, 2019